EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Vitamin D Receptor Signaling and Ligand Modulation: Molecular Mechanisms and Therapeutic Implications

Tram Thi-Ngoc Nguyen, Kouki Nojiri, Tomohiro Kurokawa, Takahiro Sawada, Yoshiaki Kanemoto, Shigeaki Kato iD

International Journal of Molecular Sciences · 04.03.2026 · 27 (5) · 2396

DOI: 10.3390/ijms27052396 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.03.2026. Verfasst von Tram Thi-Ngoc Nguyen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Iryo Sosei University, Chuodai Iino, Iwaki 970-8551, Fukushima, Japan. Hauptthemen laut MEDLINE: Receptors, Calcitriol, Signal Transduction. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Tokiwa Medical Foundation, the practical development projects by Fukushima prefecture.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vitamin D, a fat-soluble vitamin functioning as a hormone via the vitamin D receptor (VDR), is critical for calcium homeostasis and bone health. Vitamin D deficiency is linked to nutritional rickets, osteomalacia, and increased risk of non-communicable diseases such as cancer and diabetes. While serum 25(OH)D3 is used to assess vitamin D status, its active form, 1α,25(OH)2D3, exerts context-dependent effects on calcium metabolism. Nonetheless, the therapeutic utility of native vitamin D is limited in certain pathologies. In chronic kidney disease (CKD), the renal conversion of 25(OH)D3 to active 1α,25(OH)2D3 is compromised, necessitating the use of active synthetic analogs to bypass this metabolic defect. Furthermore, for dermatological and oncological disorders requiring supraphysiological dosing, synthetic analogs have been designed to dissociate beneficial anti-proliferative effects from the severe hypercalcemia induced by high-dose 1α,25(OH)2D3. VDR mediates transcriptional responses, modulated by co-regulators and chromatin remodeling complexes. Recent discoveries include non-genomic VDR pathways and SCAP (SREBP cleavage-activating protein)-dependent signaling that modulate lipid metabolism. Despite promising preclinical results, most synthetic VDR agonists fail to show efficacy in cancer therapy due to calcemic toxicity. However, compounds like eldecalcitol are effective in osteoporosis, especially in low-calcium-intake populations. Selective VDR modulators, akin to SERMs, exhibit tissue-specific effects. Moreover, novel VDR antagonists such as ZK168281 demonstrate potential to suppress hypercalcemia and vitamin D toxicity by inhibiting transcriptional activity and altering VDR localization. These agents may enable anti-inflammatory or anti-proliferative actions without calcemic risks. Understanding the nuanced biology of vitamin D and its analogs offers new avenues for therapeutic intervention beyond bone metabolism, including managing hyperparathyroidism, granulomatous diseases, and inflammation-associated disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CalcitriolSignal TransductionHumansAnimalsLigandsVitamin DCalcium

Stichwörter der Autor:innen

hypercalcemiaselective VDR modulatorssynthetic analogsvitamin D receptor (VDR)

Substanzen

Receptors, CalcitriolLigandsVitamin DCalcium

Autor:innen und Institutionen

  • Department of Pharmacy, Iryo Sosei University, Chuodai Iino, Iwaki 970-8551, Fukushima, Japan.
  • Research Institute of Innovative Medicine, Tokiwa Foundation, Iwaki 971-8112, Fukushima, Japan.
  • School of Medicine, Fukushima Medical University, Fukushima 960-1295, Fukushima, Japan.

ORCID-Profile: Shigeaki Kato

Förderung

  • Japan Society for the Promotion of Science
  • Tokiwa Medical Foundation
  • the practical development projects by Fukushima prefecture
  • JSPS
  • practical development projects by Fukushima prefecture

Zitieren

APA

Nguyen, T. T., Nojiri, K., Kurokawa, T., Sawada, T., Kanemoto, Y., & Kato, S. (2026). Vitamin D Receptor Signaling and Ligand Modulation: Molecular Mechanisms and Therapeutic Implications. International Journal of Molecular Sciences, 27(5), 2396. https://doi.org/10.3390/ijms27052396

Vancouver

Nguyen TT, Nojiri K, Kurokawa T, Sawada T, Kanemoto Y, Kato S. Vitamin D Receptor Signaling and Ligand Modulation: Molecular Mechanisms and Therapeutic Implications. International Journal of Molecular Sciences. 2026;27(5):2396. doi:10.3390/ijms27052396

BibTeX
@article{Nguyen2026,
  author = {Nguyen, Tram Thi-Ngoc and Nojiri, Kouki and Kurokawa, Tomohiro and Sawada, Takahiro and Kanemoto, Yoshiaki and Kato, Shigeaki},
  title = {Vitamin D Receptor Signaling and Ligand Modulation: Molecular Mechanisms and Therapeutic Implications},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {5},
  pages = {2396},
  doi = {10.3390/ijms27052396}
}
Kostenlos starten →